Dec 22, 2022
Brom Rector is the founder of
Empath Ventures, a VC fund that in invests in early-stage
psychedelics startups.
Prior to founding Empath, Brom sent several years as a portfolio
manager and quantitative researcher.
Brom joins the show to discuss the current state of the
psychedelics industry, the lessons learned founding a VC fund, the
differences between psychedelics and cannabis, and a whole lot
more.
Important Links:
Show
Notes:
- How Brom became interested in
psychedelic investing
- Psychedelics and the mental
health epidemic
- Depoliticising
psychedelics
- Empath Ventures’ business
model
- How we can scientifically improve
psychedelics
- The influence of hippie
culture
- A contrarian view on Big
Pharma
- The potential benefits of
ibogaine
- The differences between cannabis
and psychedelics
- Do some people not react to
psychedelics?
- Brom’s thoughts on
microdosing
- Lessons learned from founding a
VC company
- The benefits of Rule
506(c)
Books
Mentioned:
- How to Change Your Mind: What the
New Science of Psychedelics Teaches Us About Consciousness, Dying,
Addiction, Depression, and Transcendence; by Michael
Pollan
- Healing Back Pain: The Mind-Body Connection; by John E. Sarno MD